In order to confirm the mechanism how postprandial elevation of triacylglycerol is suppressed by resistant maltodextrin (Fibersol-2), we conducted the following experiments. Firstly, Rats were fed a high-fat diet with resistant maltodextrin at 0% (control), 2.5% or 5% for 5 weeks to determine the lipid amount excreted in the feces of the last three days. The total lipid and triacylglycerol excreted in rat feces were significantly increased in a dose-dependent manner by the ingestion of resistant maltodextrin. Secondly, 10 healthy adult subjects were administrated a beverage containing 5 g resistant maltodextrin or placebo for 10 days, and crossed over after an 11-day washout. Total lipid excreted in feces was determined by collecting all the feces for the last three days. Fecal weight and fecal lipid amount of the subjects increased significantly with the ingestion of resistant maltodextrin compared to the placebo ingestion. Thirdly, oil emulsion prepared with resistant maltodextrin was assessed for its hydrolysis rate by lipase. The hydrolysis rate of lipid by lipase was not affected by resistant maltodextrin. Lastly, micelle emulsion was prepared with or without resistant maltodextrin, and their stability was compared. Resistant maltodextrin inhibited the decomposition of micelles and stabilized micellar structure. From these results, it was suggested that resistant maltodextrin suppresses lipid absorption and promotes the excretion of lipid into feces by delaying the release of fatty acids from micelles in the lipid absorption process. No inhibitory effect on lipase activity was observed by resistant maltodextrin.
INTRODUCTION
Postprandial elevation of blood triacylglycerol is known to relate closely to the onset and development of arteriosclerosis and coronary artery diseases. 1, 2) It is desirable that postprandial elevation of blood triacylglycerol is controlled for the prevention of these diseases. In recent years, oolongtea polyphenols, coffee oligosaccharides, and others have been found to inhibit the digestion and absorption of lipid in food by inhibiting lipase activity and facilitate lipid excretion. The food products formulated with these substances are known to suppress the rapid rise in blood triacylglycerol after meals. 3, 4) In addition, it is also known that high-viscous * To whom correspondence should be addressed: Research Laboratory, Matsutani Chemical Industry Co., Ltd., 5-3 Kita-itami, Itami, Hyogo 664-8508, Japan. Tel.: +81-72-771-2052; Fax: +81-72-771-2023; E-mail: yuka-kishimoto@matsutani.co.jp water-soluble dietary fibers, such as psyllium affect digestion and absorption of nutrients. Digestion and absorption of lipid are also delayed by high-viscous soluble dietary fibers. 5) However, resistant maltodextrin (RMD) and hydrolyzed guar gum, which are non-viscous soluble dietary fibers and do not form a gel in the digestive tract, have also been reported to suppress postprandial elevation of triacylglycerol. 6, 7) Hydrolyzed guar gum has been reported to physically inhibit the formation of lipidbile acid emulsion without inhibiting lipase activity. 8) As for RMD, its suppressive effect on postprandial rise in triacylglycerol was observed in animal and human studies, 6, 9, 10) however, its mechanism has not been clarified yet. We conducted this study to investigate the RMD mechanism to suppress the postprandial elevation of triacylglycerol.
C 2009 The Pharmaceutical Society of Japan Table 1 . Soft drinks containing 5 g of RMD (test beverage) or no RMD (placebo control) were prepared with lemon flavor, citric acid, and coloring. Both were filled in an unmarked plastic bottle with a 280 ml net volume, and confirmed before the experiment that both beverages were not distinguishable in appearance or taste.
MATERIALS AND METHODS

Material
In this double-blind crossover study, the subjects were randomly divided and assigned to two groups, and given either the test or placebo beverage at every meal time, three times per day for 10 days. All feces during the last 3 days were collected, as the fecal collection period. After an 11-day washout, the treatment with the crossover beverage was conducted in the same manner. The meals during the treatment periods were prepared to control the nutrient amounts. During both treatments, the subjects took the same meals in the same order to consume a uniform amount of nutrients. Fecal lipid concentration was measured according to the analytical method by Kamer et al. 14) Average daily lipid excretion in the feces was calculated by using the obtained fecal weight and lipid concentration. Effect on Lipase Activity --Lipid emulsion was prepared as follows; 0.5 g sodium taurocholate and 5 g corn oil were added to 20 ml of a 20% RMD solution or distilled water, and homogenized at 21500 rpm for 3 min with a homogenizer (UltraTurrax T-25 Basic, IKA-Werke GmbH & Co. KG., Staufen, Germany). After a 2-hr rest period, 150 µl of the emulsion was taken from the upper layer and then suspended in 600 µl Tris-HCl buffer (pH 8.5). Then 300 µl of porcine pancreatic lipase (Elastin Products Co. Inc., Owensville, MO, U.S.A.) diluted to 400 unit/ml with Tris-HCl buffer (pH 8.5) was added to the diluted emulsion at 37 • C, and the concentration of released fatty acid was measured at 0, 20, 30 and 60 min by an enzymatic method (NEFA C-Test Wako, Wako Pure Chemical Industries, Ltd.). Stabilization of Micelle --Micelle emulsion was prepared as follows; 0.5 g of sodium taurocholate and 2 g of 2 : 1 (molar ratio) oleic acidmonoolein mixture were added to 20 ml of a 20% RMD solution or distilled water, and homogenized at 21500 rpm for 3 min by using a homogenizer (described above). The micelle emulsion was let stand still at 37 • C and the condition of the emulsion was observed visually at 0 (start), 60, 120 and 180 min with the measurement of absorbance and average particle diameter. As the indicator of transmittance, absorbance at 500 nm was measured for 1/400 dilution with 0.1% sodium dodecyl sulphate (SDS). Average particle diameter was measured using a particle size distribution analyzer (Microtrack, Nikkiso Co., Ltd., Tokyo, Japan). Statistical Analysis --Results were described as mean ± standard error of the mean (SEM). The significance of differences between groups was assessed by the one-way analysis of variance (ANOVA) and Turkey's multiple comparisons, and for the comparison between two groups, a paired ttest was carried out. For all tests, p < 0.05 was used as the critical level of significance. A statistical software program, SPSS (Version 11, SPSS Japan, Tokyo, Japan) was used for the analysis.
RESULTS
Fecal Lipid Excretion (Rat)
No significant differences were found in cumulative feed consumption, weight gain, or body weight at the end of the feeding period. In Table 2 , fecal dry weight and fecal lipid data for the last 3 days are shown along with weight of abdominal adipose tissue at the end of the feeding period. Fecal dry weight increased significantly corresponding to the dose of RMD, where the fecal dry weight of 5% RMD (2.38 ± 0.12 g/3 days) was about 30% larger than that of HF (1.81 ± 0.06 g/3 days). For the fecal lipid concentrations, no differences were found in either total lipid or triacylglycerol. However, the total excreted amount of total lipid and triacylglycerol was significantly larger in 5% RMD compared to HF, reflecting the significant increases in total fecal amount. The 5% RMD group excreted about 50% more total lipid, and about 30% more triacylglycerol compared to HF. Correspondingly, the amount of abdominal adipose tissue significantly decreased in the RMD groups compared to HF, showing negative correlation with the dose of RMD.
Fecal Lipid Excretion (Human)
The intakes of energy and fat during the treatment periods are shown in Table 3 , with no significant differences between placebo and test. The results of fecal weight, lipid concentration and lipid amount per day are shown in Table 4 . For the fecal lipid concentration, no significant differences were found between placebo and test, however, the fecal weight was significantly larger (p = 0.023) in the test beverage treatment (129.7 ± 24.5 g/day), compared to the placebo (73.6 ± 13.1 g/day). Correspondingly, the excreted lipid amount was significantly larger (p = 0.034) for the test beverage treatment (1.44 ± 0.1 g/day) than that of the placebo treatment (0.77 ± 0.1 g/day).
Effect on Lipase Activity
The release rate of fatty acids by lipase from the emulsion is shown in Fig. 1 . The release of free fatty acids from micelle was observed over time as the lipase-catalyzed reaction. RMD did not inhibit the release of fatty acids from the emulsion.
Stabilization of Micelle
The control micelle emulsion prepared without RMD was unstable, separating fatty acids and monoacylglycerol to form an upper oil layer in 180 min. However, the micelle emulsion prepared with RMD showed no separation of oil at 180 min. The changes in absorbance at 500 nm of micelle emulsion and average particle diameter of micelle are shown in Fig. 2 . Absorbance of the control micelle emulsion decreased to less than 50% in 60 min, while that of the micelle emulsion containing RMD decreased about 20%. Similarly, the decrease of average particle diameter in 180 min was also smaller in the micelle emulsion with RMD, with an 80% decrease for the control micelle emulsion and a 40% decrease for the micelle emulsion with RMD.
DISCUSSION
In this study we conducted a series of experiments in order to investigate the mechanism of RMD to suppress postprandial elevation of blood triacylglycerol.
Polyphenols have been reported to suppress postprandial elevation of triacylglycerol by promoting lipid excretion into feces, 15, 16) so we considered that RMD would also have a similar function; promotion of lipid excretion. We conducted the animal and human experiments to confirm the effect of RMD on the lipid excretion into feces. In the animal experiment, we employed a highfat diet containing 21% fat instead of the standard rat diet AIN93, which contains 7% fat. As a result, total lipid and triacylglycerol excreted in feces were increased by ingestion of RMD dose-dependently, showing significant differences between the control and 5% RMD.
In the human study, the meal provided to subjects contained 55 g of fat per day (about 26% energy from fat) based on the National Nutrition Survey 17) for the average nutritional intake of modern Japanese. Since the recommended daily energy intake from fat for Japanese is 20-25%, 18) 26% energy from fat in this study was slightly high, adapting to the actual eating patterns of Japanese. Consistent with the animal study, the concentration of fecal lipid did not change, however, the total excretion of lipid increased as increasing total fecal weight. It has been reported that lipid excretion in feces increased by the administration of oolong tea polyphenols. 16) In the polyphenol study, fecal lipid concentration (estimated from the reported data) seemed to stay in similar levels as shown in our current study, suggesting a possibility that there may be some upper limit for fecal lipid concentration while keeping normal fecal shape and conditions.
The fecal lipid excretion during the placebo treatment in this study (0.77 ± 0.1 g/day) matches well with a previous report. 15) Fecal lipid excretion is considered to correspond with the lipid amount not absorpted in the small intestine, because lipid is not hydrolyzed or utilized by intestinal bacteria, unlike protein or carbohydrates. 19) Since the lipid excretion was significantly increased by the ingestion of RMD, it has been verified that RMD was associated with the reduction of lipid absorption.
Our assumption from animal experiments that RMD increases the excretion of lipids in feces has been verified in human for the first time in this study, although the increase in fecal weight by the supplementation of RMD has been reported in a large number of human studies. 20, 21) Then we conducted a further investigation to illustrate the mechanism of how RMD suppresses lipid absorption. The process of lipid digestion and absorption consists of two processes; the digestion process and the absorption process. In the former, lipids are hydrolyzed by lipase to fatty acids and monoacylglycerol. In the latter, the produced fatty acids and monoacylglycerol form micelles with bile acids and phospholipids. The micelles are transported through the digestive tract and broken on the brush-border membrane. Fatty acids and monoacylglycerol are released from the broken micelles, to be absorbed into the body through the intestinal mucosa. In the lipid absorption process, stabilization of micelle is considered to be effective to delay the release of fatty acids and monoacylglycerol.
As it was observed that RMD does not affect the hydrolysis rate of lipid by lipase-the lipid digestion process, we examined the association of RMD in the lipid absorption process. We prepared model micelle with fatty acids, monoacylglycerol and taurocholic acid to observe its stability. The release of fatty acids and monoacylglycerol from the micelle containing RMD was delayed, showing small changes in the absorbance and average particle diameter compared to the control micelle. By adding RMD, the stabilization of micelle was observed.
In conclusion, the results in the present study supported our hypothesis that the mechanism for RMD to suppress the elevation of postprandial triacylglycerol is the promotion of the lipid excretion into feces by delaying the release of fatty acids and monoacylglycerol from micelles.
In the food industry, maltodextrin has been used as an emulsion stabilizer based on its physical property. Similarly, or superior to regular maltodextrin, RMD also has a property to stabilize emulsion, because RMD has a high ratio of 1-6 glucosidic bonds-branched structure. 22) As shown in this study, RMD would work as an emulsion stabilizer even in the digestive tract, for RMD is not hydrolyzed by digestive enzymes and passes through the small intestine. In order to confirm that the stabilization of micelle found in the in vitro experiment is consistent with in vivo, we will conduct further investigations such as in situ experiments.
For clinical treatment, a lipase inhibitor that promotes lipid excretion is used as a medicine for obesity, however, because of the strong lipase inhibitory action; it also causes undesirable symptoms such as steatorrhea, loose stools, diarrhea, malabsorption of fat-soluble vitamins, etc. RMD did not affect the lipid concentration in feces in either animal or human without experiencing steatorrhea. Further, deficiency of fat soluble vitamins was not observed in the human study, in which subjects ingested 60 g per day of RMD for 3 months. 23 ) From these evidences, we believe that the mechanism of RMD to promote fat excretion is not too strong and would not cause any adverse effects from the daily consumption of RMD.
